Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis
Abstract In the absence of a validated correlate of protection or robust animal models for human tuberculosis, Mycobacterial growth inhibition assays (MGIAs) aim to assess vaccines ability to inhibit mycobacterial growth in-vitro. We optimised a reproducible murine splenocyte MGIA based on in-vitro...
Guardado en:
Autores principales: | Christina Jensen, Line Lindebo Holm, Erik Svensson, Claus Aagaard, Morten Ruhwald |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e0ea4720731f40618c6dd121172296d2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
por: Hannah Painter, et al.
Publicado: (2020) -
MYCOBACTERIUM TUBERCULOSIS VIRULENCE
por: B. I. Vishnevskiy, et al.
Publicado: (2015) -
Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
por: Kidola Jeremiah, et al.
Publicado: (2021) -
Sunroot mediated synthesis and characterization of silver nanoparticles and evaluation of its antibacterial and rat splenocyte cytotoxic effects
por: Aravinthan A, et al.
Publicado: (2015) -
Cell proliferation assay – method optimisation for in vivo labeling of DNA in the rat forestomach
por: Joksić Gordana, et al.
Publicado: (2017)